HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers - A prospective, mulicenter, controlled, randomized clinical trial

被引:116
作者
Caravaggi, C
De Giglio, R
Pritelli, C
Sommaria, M
Dalla Noce, S
Fagila, E
Mantero, M
Clerici, G
Fratino, P
Dalla Paola, L
Mariani, G
Mingardi, R
Morabito, A
机构
[1] Osped Abbiategrasso, Ctr Study & Treatment Diabet Foot Pathol, Milan, Italy
[2] Policlin Multimedia, Sesto San Giovanni, Milan, Italy
[3] Fdn Maugeri, Ctr Prevenz & Cura Piede Diabet, Pavia, Italy
[4] Casa Cura Villa Ber, Vicenza, Italy
[5] Osped San Carlo Borromeo Milano, Div Med, Milan, Italy
[6] Osped San Bortolo, Vicenza, Italy
[7] Univ Milan, Inst Med Stat & Biometry, I-20122 Milan, Italy
关键词
D O I
10.2337/diacare.26.10.2853
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
OBJECTIVE-To evaluate the clinical efficacy and safety of HYAFF 11-based autologous dermal and epidermal grafts in the management of diabetic foot ulcers. RESEARCH DESIGN AND METHODS-A total of 79 patients with diabetic dorsal (n = 37) or plantar (n = 42) ulcers were randomized to either the control group with non-adherent paraffin gauze (n = 36) or the treatment group with autologous tissue-engineered grafts (n = 43). Weekly assessment, aggressive debridement, wound infection control, and adequate pressure relief (fiberglass off-loading cast for plantar ulcers) were provided in both groups. Complete wound healing was assessed within 11 weeks. Safety was monitored by adverse events. RESULTS-Complete ulcer healing was achieved in 65.3% of the treatment group and 49.6% of the control group (P = 0.191). The Kaplan-Meier mean time to closure was 57 and 77 days, respectively, for the treatment versus control groups. Plantar foot ulcer healing was 55% and 50% in the treatment and control groups, respectively. Dorsal foot ulcer healing was significantly different, with 67% in the treatment group and 31% in the control group (P = 0.049). The mean healing time in the dorsal treatment group was 63 days, and the odds ratio for dorsal ulcer healing compared with the control group was 4.44 (P = 0.037). Adverse events were equally distributed between the two groups, and none were related to the treatments. CONCLUSIONS-The autologous tissue-engineered treatment exhibited improved healing in dorsal ulcers when compared with the current standard dressing. For plantar ulcers, the off-loading cast was presumably paramount and masked or nullified the effects of the autologous wound treatment. This treatment, however, may be useful in patients for whom the total off-loading cast is not recommended and only a less effective off-loading device can be applied.
引用
收藏
页码:2853 / 2859
页数:7
相关论文
共 29 条
[1]
ANDREASSI L, 1991, WOUNDS, V3, P116
[2]
[Anonymous], DIABETES CARE
[3]
Off-loading the diabetic foot wound - A randomized clinical trial [J].
Armstrong, DG ;
van Schie, CHM ;
Nguyen, HC ;
Boulton, AJM ;
Lavery, LA ;
Harkless, LB .
DIABETES CARE, 2001, 24 (06) :1019-1022
[4]
Armstrong DG, 1998, J REHABIL RES DEV, V35, P1
[5]
ATILLASOY E, 2000, WOUNDS, V12, pA3
[6]
Semisynthetic resorbable materials from hyaluronan esterification [J].
Campoccia, D ;
Doherty, P ;
Radice, M ;
Brun, P ;
Abatangelo, G ;
Williams, DF .
BIOMATERIALS, 1998, 19 (23) :2101-2127
[7]
Caravaggi C, 2000, INT CONGR SER, V1196, P313
[8]
Effectiveness and safety of a nonremovable fiberglass off-bearing cast versus a therapeutic shoe in the treatment of neuropathic foot ulcers - A randomized study [J].
Caravaggi, C ;
Faglia, E ;
De Giglio, R ;
Mantero, M ;
Quarantiello, A ;
Sommariva, E ;
Gino, M ;
Pritelli, C ;
Morabito, A .
DIABETES CARE, 2000, 23 (12) :1746-1751
[9]
METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[10]
Faglia E, 1999, WOUNDS, V11, P105